L. A. Mija and A. Elkrief, “Clinical Considerations for the Management of Advanced PD-L1 ≥50% Non-small Cell Lung Cancer In 2025: Should All Patients Be Treated the Same?”, Can Oncol Today, vol. 2, no. 1, pp. 13–17, Apr. 2025.